Solid composition comprising a clay such as kaolin
AssigneeGlaxoSmithKline Consumer Healthcare GmbH & Co. KG
InventorsStefanie Christian, Michael Harkenthal, Ulrich Thomas Schobert
Life of this patent
Estimating the term…
Abstract
The present invention relates to a therapeutic composition comprising at least one clay, at least one disintegrant, at least one lubricant and at least one binding agent, particularly wherein the at least one clay is kaolin, and in particular to a palatable clay composition in the form of a tablet, and to a process for the preparation of the therapeutic composition
Claims22
A therapeutic composition comprising at least one clay, at least one disintegrant, at least one lubricant and at least one binding agent.
(canceled)
A therapeutic composition for oral delivery in the form of a tablet comprising:
- 1) at least one clay;
- 2) at least one disintegrant selected from the group consisting of sodium starch glycolate, crosslinked povidone, calcium carboxymethylcellulose and crosslinked carboxymethylcellulose, and combinations of two or more thereof;
- 3) at least one lubricant selected from the group consisting of fumaric acid, magnesium lauryl sulphate, solid polyethylene glycol, sodium lauryl sulphate, calcium behenate, calcium arachinate, sodium stearyl sulphate, and combinations of two or more thereof;
- 4) and at least one binding agent least one binding agent selected from the group consisting of microcrystalline cellulose, sorbitol, mannitol, polyvinylpyrrolidone (PVP), calcium phosphate, saccharose (sucrose) and lactose, and combinations of two or more thereof;
- and
- 5) optionally a colouring agent, flavouring agent, compression aid, preservative, wetting
Dependencies are inferred from the claim text.